| Fresenius Kabi (Schweiz) AG - Piperacillin/Tazobactam Fresenius i.v. 2 g/0.25 g, Pulver zur Herstellung einer Infusionslösung |
| 63001 | | 01 | | Piperacillin/Tazobactam Fresenius i.v. 2 g/0.25 g | | Pulver zur Herstellung einer Infusionslösung | | J01CR05 | | Piperacillin and Beta-Lactamase Inhibitor | | 05.12.2013 | | |
|
| Composition |
| Praeparatio cryodesiccata: piperacillinum 2 g ut piperacillinum natricum 2.085 g, tazobactamum 250 mg ut tazobactamum natricum 268.3 mg, pro vitro corresp. natrium 112 mg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate | | | | | | | | Active Agent | Dose |
|---|
| Piperacilline | 2 g | | Tazobactame | 250 mg |
| | BAG: Active Agent | Dose |
|---|
| Piperacilline | 2 g | | Tazobactame | 0.25 g |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Flasche(n) | 9.75 | 27.00 | A | SL | No | | 002 | 10 Flasche(n) | | | A | | Yes |
|
